Champions Oncology (CSBR) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 36.13% |
| Apr 30, 2026 | -139.07% |
| Jan 31, 2026 | -217.72% |
| Oct 31, 2025 | 150.86% |
| Jul 31, 2025 | 74.60% |
| Apr 30, 2025 | -140.82% |
| Jan 31, 2025 | 517.45% |
| Oct 31, 2024 | -44.55% |
| Jul 31, 2024 | 1,304.59% |
| Apr 30, 2024 | 95.69% |
| Jan 31, 2024 | -22.16% |
| Oct 31, 2023 | 19.29% |
| Jul 31, 2023 | -0.20% |
| Apr 30, 2023 | -5.00% |
| Jan 31, 2023 | -15,143.75% |
| Oct 31, 2022 | 94.98% |
| Jul 31, 2022 | 7.27% |
| Apr 30, 2022 | -143.71% |
| Jan 31, 2022 | 184.12% |
| Oct 31, 2021 | 261.05% |